Study to Evaluate the Efficacy of Riluzole in Children and Young Adults With Spinal Muscular Atrophy (SMA)
PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment
141
Participants
Timeline
Start Date
January 31, 2006
Primary Completion Date
September 30, 2011
Study Completion Date
December 31, 2011
Conditions
SMA
Interventions
DRUG
Riluzole
50 mg per day during 24 months
Trial Locations (1)
92380
Hopital Raymond Poincare, Garches
All Listed Sponsors
lead
Assistance Publique - Hôpitaux de Paris
OTHER
NCT00774423 - Study to Evaluate the Efficacy of Riluzole in Children and Young Adults With Spinal Muscular Atrophy (SMA) | Biotech Hunter | Biotech Hunter